###begin article-title 0
Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma
###end article-title 0
###begin p 1
###xml 29 44 29 44 <email xmlns:xlink="http://www.w3.org/1999/xlink">epnere@ohsu.edu</email>
CORRESPONDENCE Elliot Epner: epnere@ohsu.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 422 431 422 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 699 706 <span type="species:ncbi:9606">patient</span>
###xml 1067 1072 <span type="species:ncbi:9606">human</span>
In mantle cell lymphoma (MCL) and some cases of multiple myeloma (MM), cyclin D1 expression is deregulated by chromosome translocations involving the immunoglobulin heavy chain (IgH) locus. To evaluate the mechanisms responsible, gene targeting was used to study long-distance gene regulation. Remarkably, these targeted cell lines lost the translocated chromosome (t(11;14)). In these MCL and MM cells, the nonrearranged cyclin D1 (CCND1) locus reverts from CpG hypomethylated to hypermethylated. Reintroduction of the translocated chromosome induced a loss of methylation at the unrearranged CCND1 locus, providing evidence of a transallelic regulatory effect. In these cell lines and primary MCL patient samples, the CCND1 loci are packaged in chromatin-containing CCCTC binding factor (CTCF) and nucleophosmin (NPM) at the nucleolus. We show that CTCF and NPM are bound at the IgH 3' regulatory elements only in the t(11;14) MCL cell lines. Furthermore, NPM short hairpin RNA produces a specific growth arrest in these cells. Our data demonstrate transvection in human cancer and suggest a functional role for CTCF and NPM.
###end p 3
###begin p 4
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
Abbreviations used: CCND1, cyclin D1; ChIP, chromatin immunoprecipitation; CTCF, CCCTC binding factor; FISH, fluorescent in situ hybridization; immunoFISH, immunofluorescent FISH; LCL, lymphocyte cell line; LCR, locus control region; MCL, mantle cell lymphoma; MM, multiple myeloma; MSP, methylation-specific PCR; MTC, major translocation cluster; NPM, nucleophosmin; Pol II, RNA polymerase II; shRNA, short hairpin RNA; TUNEL, Tdt-mediated dUTP-biotin nick-end labeling.
###end p 4
###begin p 5
H. Liu and J. Huang contributed equally to this paper.
###end p 5
###begin p 6
H. Liu's present address is Nimblegen Systems, Madison, WI 53711.
###end p 6
###begin p 7
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 292 293 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 295 296 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 619 623 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CMYC</italic>
###xml 625 626 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 628 629 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 635 644 630 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D1</italic>
###xml 646 651 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 654 655 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 657 658 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 771 772 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 804 805 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 860 861 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 244 247 <span type="species:ncbi:8790">Emu</span>
B cell malignancies such as non-Hodgkin's lymphoma and multiple myeloma (MM) are characterized by 14q32 translocations involving the IgH locus (1). These translocations serve to juxtapose IgH regulatory elements, such as the intronic enhancer (Emu;1) or 3' Calpha locus control region (LCR) (2, 3), that deregulate transcription of target genes over several hundred kilobases of DNA. The mechanisms involved in long-distance deregulation of target genes by IgH regulatory elements are unknown; however, regulatory elements in the IgH locus are thought to derepress or increase the transcription of target genes such as CMYC (1, 2) and cyclin D1 (CCND1) (1, 4) that are involved in B cell malignancies. Epigenetic changes in chromatin structure involving DNA methylation (5) and/or histone modifications (6) have been implicated in deregulated gene expression (4).
###end p 7
###begin p 8
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 582 587 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 594 595 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 597 598 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 750 755 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 762 763 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 786 791 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 793 798 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyeOV</italic>
###xml 833 838 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 900 901 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1078 1083 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1094 1096 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 495 498 <span type="species:ncbi:8790">Emu</span>
The activation of the CCND1 gene that occurs in mantle cell lymphoma (MCL) and a subset of MM was used as a model system to investigate the mechanisms responsible for long-distance gene deregulation in B cell malignancies (see Fig. 1 A). Cyclin D1 is not expressed in normal lymphocytes, where the unlinked family members cyclin D2 and/or D3 are active (7). In B cell malignancies, cyclin D1 gene expression is activated by the insertion or translocation of IgH regulatory elements, such as the Emu intronic or 3' Calpha enhancer/LCR, that can be as far as 100-300 kb away from the CCND1 gene (4, 8). The majority of the breakpoints in MCL map to the major translocation cluster (MTC) region located approximately120 kb upstream (centromeric) of the CCND1 gene (8). The nearest gene to CCND1, MyeOV, is located 360 kb centromeric to CCND1 and is expressed in a subset of t(11;14) MM, but not in MCL (9). Although translocations involving the t(11;14) are most common, the MM cell line U266 contains an insertion of IgH regulatory sequences approximately10 kb centromeric of the CCND1 promoter (10).
###end p 8
###begin p 9
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
The CCND1 promoter contains a CpG island that can be potentially regulated by DNA methylation (4, 11). We have found that in normal B cells the CCND1 locus is organized into hypomethylated DNA bound by acetylated nucleosomes. Analysis of the CCND1 DNA methylation status in MM and MCL cell lines with t(11;14) indicates that the deregulated as well as the normal, silent CCND1 loci are CpG hypomethylated (4).
###end p 9
###begin p 10
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 160 178 160 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascobolus immerses</italic>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
Control of DNA methylation in mammalian cells has been shown to involve a cis-acting mechanism (12). However, observations in higher plants (13-15), the fungus Ascobolus immerses (16), and more recently in mice (13, 17) demonstrated that DNA methylation can also be regulated in trans by interactions between homologous chromosomes.
###end p 10
###begin p 11
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 665 673 665 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2/H19</italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
A ubiquitous, complex protein that has emerged as a critical mediator of multiple epigenetic processes is the zinc finger protein CCCTC binding factor (CTCF). CTCF is a highly conserved, 11 zinc finger protein first identified as a c-myc binding factor and subsequently shown to bind to metazoan regulatory elements known as insulators (18). Insulator elements, which act from an intervening position to prevent flanking cis-acting elements from interacting, mediate their function through CTCF (18, 19). Furthermore, the binding of CTCF to insulator elements is blocked by CpG methylation, allowing interactions between distal regulatory elements in the imprinted Igf2/H19 locus (19, 20). Recent evidence has identified the nucleolar protein nucleophosmin (NPM) as a major CTCF-interacting protein that functions to tether promoters and regulatory elements separated by large linear distances together at the nucleolar periphery (21).
###end p 11
###begin p 12
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1236 1241 <span type="species:ncbi:9606">human</span>
To investigate the mechanisms of long-distance activation of the CCND1 gene by the IgH enhancer/LCR, homologous recombination was used to target regulatory regions potentially involved in cyclin D1 deregulation. Recombinants that lost the translocated chromosome also lost the ability to maintain hypomethylation at the normal CCND1 allele. These clones no longer expressed cyclin D1. These findings suggest that the translocated chromosome exerts a long-distance cis DNA hypomethylating effect on the linked CCND1 promoter as well as a transallelic effect on the unlinked CCND1 promoter on the homologous chromosome. Thus, in the absence of the translocated chromosome, the unrearranged CCND1 locus is densely DNA methylated. CTCF and NPM are associated with both the translocated and unrearranged CCND1 loci in cell lines with t(11;14). Interestingly, binding of these proteins at the unrearranged CCND1 locus is dependent on the presence of the translocated allele. These results provide further evidence that long-distance control of DNA methylation in mammalian cells can be communicated in trans, and demonstrate a novel mechanism for chromosome structure and nuclear organization to participate in deregulated gene expression in human malignancy.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
B cell lines that have lost the t(11;14) translocation do not express cyclin D1 and have altered DNA methylation patterns at the unrearranged CCND1 locus
###end title 14
###begin p 15
###xml 444 446 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 488 496 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 751 759 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1201 1209 1195 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1347 1362 1341 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, D and E</xref>
###xml 105 110 <span type="species:ncbi:9606">human</span>
A gene targeting strategy was designed to study regulatory regions involved in cyclin D1 deregulation in human B cell malignancies. Our initial approach was to target the potential regulatory regions involved in long-distance cyclin D1 deregulation in B cell malignancies. By analogy, results in the beta-globin locus demonstrated that insertion of a selectable marker gene into the beta-globin LCR abrogated transcription of downstream genes (22). Two gene targeting vectors (TV1 and 2; Fig. 1 A) were constructed and electroporated into two MCL cell lines, Granta 519 (Granta [G]) and NCEB-1 (NCEB [N]), and the MM cell line U266 (U), all of which express cyclin D1. The initial Southern blot analysis was consistent with successful gene targeting (Fig. 1 B); however, subsequent analyses showed instability and loss of the targeted/translocated chromosomes. Additional clones were isolated using TV1 in NCEB (N1-3) cells, and TV2 in U266 (LU clones) and Granta (LG clones) cells. Southern blot analysis using cell line-specific translocation breakpoint probes (P519 for Granta and MTC for NCEB) demonstrated the absence of translocated chromosome breakpoint sequences in the mutant MCL cell lines (Fig. 1 C). Fluorescent in situ hybridization (FISH) analysis demonstrated that the translocated chromosomes had been lost in all of these clones (Fig. 1, D and E; and Table S1, available at ).
###end p 15
###begin p 16
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Derivative MCL and MM cell lines have lost t(11;14).</bold>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R</sup>
###xml 225 230 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 271 272 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R</sup>
###xml 959 964 943 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1193 1198 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 296 301 <span type="species:ncbi:9606">human</span>
Derivative MCL and MM cell lines have lost t(11;14). (A) Maps of the 11q13 and 14q32 regions with the locations of the gene targeting events. TV1 inserts the neoR gene into the MTC region, approximately120 kb upstream of the CCND1 gene on chromosome 11. TV2 inserts a neoR gene downstream of the human IgH 3'alpha1 LCR region on chromosome 14. (B) Southern blot analysis of U266 parental (U) and TV1-transfected clones (U1-11). Maps of the vector, the endogenous locus, and the targeted clone U7 are shown. (C) Southern blot analysis of MCL parental and mutant cell lines. Genomic DNA from the Granta parental cell line (G) and its targeted derivatives (G4, LG1, and LG2) were analyzed with the Granta breakpoint (P519) probe, and genomic DNA from the parental cell line NCEB1 (N) and its targeted derivatives (N1, N2, and N3) were analyzed with the NCEB1 breakpoint (MTC) probe. Both parental lines have both translocated (Trans.) and nontranslocated (Nor.) CCND1 loci, whereas the derivatives retain only the normal chromosome. The map depicts the locations of the cell line breakpoints. (D) FISH analysis of MCL parental and mutant cell lines. A centromeric probe for chromosome 11 and IgH/CCND1 fusion probes revealed loss of the translocated t(11;14) in the derivative cells lines. A more detailed description is provided in Supplemental results (available at ). (E) FISH analyses show the presence of the variant t(11;14) insertion in the U266 MM cell line and its absence in derivative cell lines (LU1 and LU2). Table S1 provides a summary. Bars, 15 mum.
###end p 16
###begin p 17
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 337 352 337 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 424 432 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
We assessed the expression of D-type cyclins in each of the parental and targeted MCL cells to determine whether loss of t(11;14) affected expression of the remaining cyclin D alleles. Parental Granta and NCEB MCL cells expressed cyclin D1 (4). However, the derivative MCL cell lines, which had lost t(11;14), did not express cyclin D1 (Fig. 2, A and B). Instead, up-regulation of cyclin D3 mRNA (not depicted) and protein (Fig. 2 C) levels was observed, presumably to compensate for the loss of cyclin D1 that has been observed in other experimental cell culture and animal systems (23, 24).
###end p 17
###begin p 18
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of D-type cyclin protein levels in parental and mutant clones.</bold>
###xml 498 499 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 569 570 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 798 799 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 885 886 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 895 902 <span type="species:ncbi:9031">Chicken</span>
Analysis of D-type cyclin protein levels in parental and mutant clones. (A) IP Western blot analysis of cyclin D1 protein in parental and mutant NCEB and Granta MCL cell lines. Cyclin D1 protein is not detectable in mutant clones. (B) IP Western blot analysis of cyclin D1 protein in control and mutant U266 MM clones. Parental U266 cells express cyclin D1 protein, whereas all the mutant clones express no cyclin D1 protein. (C) Western blot analysis of cyclin D3 protein in parental and cyclin D1- MM and MCL cells. Abundant cyclin D3 protein is observed in cyclin D1- cell lines. Parental MCL and MM lines express minimal amounts of cyclin D3 protein. The white line indicates that intervening lanes have been spliced out. (D) Western blot analysis of cyclin D2 protein in parental and cyclin D1- MCL clones. Cyclin D2 protein is present at low levels in both parental and cyclin D1- clones. Chicken DT40 cells were used as a negative control. Manca (Ma), RD, and DHL-4 cells were used as positive controls. M, marker.
###end p 18
###begin p 19
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 254 262 254 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 475 483 475 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 784 799 784 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, B and C</xref>
DNA methylation patterns within the CCND1 locus in the variant cyclin D1- MCL cells were analyzed. The CCND1 promoter region and sequences 3 kb upstream were extensively methylated, as shown by Southern blot analysis (Fig. 3 B) and bisulfite sequencing (Fig. 3 C). DNA methylation changes occurred in sequences 90 kb (P519) upstream of the CCND1 gene. Because the translocation breakpoints in the NCEB and Granta cell lines are located at the 3' end and proximal to the MTC (Fig. 3 A), respectively, most of this region lies on the reciprocal translocation partner. At the MTC, CpG sequences such as at the Hpa II/Msp site remained hypomethylated in both cyclin D1-expressing and nonexpressing clones. Similar results were obtained with independently isolated Granta and NCEB clones (Fig. 3, B and C).
###end p 19
###begin p 20
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNA methylation analysis of the parental and cyclin D1<sup>&#8722;</sup> cell lines.</bold>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 958 963 958 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
DNA methylation analysis of the parental and cyclin D1- cell lines. (A) Schematic representation of the 11q13 locus. Breakpoints, probes used, regions studied by bisulfite sequencing, and their positions relative to the CCND1 gene are shown. (B) Analysis of DNA methylation in Granta (G) versus G4, LG1, and LG2 cell lines, and NCEB (N) versus N1, N2, and N3 cell lines. Isolated DNA from each line was cut with Hind III + Msp (M) or Hpa II (H) and Southern blotted. (C) Bisulfite sequencing in G4 and N1 cell lines. Extensive remethylation of the promoter and 3-kb upstream regions compared with parental cell lines Granta and NCEB, and remethylation of some sites in the P519 region located 90 kb upstream of the CCND1 gene are observed. (D) Analysis of DNA methylation in U266 and variant cell lines by Southern blotting. The CCND1 promoter region and upstream region P519 are unmethylated in U266 cells and methylated in nonexpressing LU1 and LU2 cells. CCND1-expressing MM cell lines KMS12 and KMS21BM (t(11;14)+) are unmethylated in all regions examined, similar to U266 cells.
###end p 20
###begin p 21
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
DNA methylation in the cyclin D1- genetic variants was also assayed by methylation-specific PCR (MSP) (25), which complements the Southern blotting and sodium bisulfite sequencing approaches (26). MSP analysis of the CCND1 promoter and the 3-kb upstream regions in Granta, NCEB, G4, and N1 cells revealed that both regions were heavily CpG methylated in the genetic variants (Fig. S1, available at ).
###end p 21
###begin p 22
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
These data are consistent with a model in which the translocated chromosome exerts a transallelic hypomethylating effect on the nontranslocated chromosome in MCL parental cell lines. This effect disappeared in the targeted variants with the loss of the translocated chromosome, leading to extensive methylation of the CCND1 locus. The transallelic hypomethylating effect extended from the CCND1 promoter at least to the P519 region 90 kb upstream.
###end p 22
###begin p 23
###xml 320 325 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 336 338 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 467 475 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 531 539 519 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 652 654 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
To determine if our observations in MCL cells were applicable to cyclin D1-expressing MM cells that contained an insertion of IgH sequences instead of the classical t(11;14), we analyzed similar variant clones from parental U266 cells that contain IgH regulatory sequences inserted approximately10 kb centromeric of the CCND1 promoter (12). Similar to the variant Granta and NCEB clones, U7, LU1, and LU2 clones were isolated where the active chromosome 11 was lost (Fig. 1 E; and Table S1), and no cyclin D1 protein was detected (Fig. 2 B). In addition, two other control MM cell lines that contain t(11;14) and express cyclin D1 (KMS12 and KMS21BM) (27) were analyzed.
###end p 23
###begin p 24
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 270 278 270 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Analysis of the DNA methylation status at the CCND1 locus in the parental MM cell lines and the U266 cyclin D1- derivatives revealed that the CCND1 promoter and P519 regions were hypomethylated in all of the cyclin D1+ MM cell lines, including U266, KMS12, and KMS21BM (Fig. 3 D), similar to the results obtained with the parental Granta and NCEB MCL cell lines. In contrast, DNA hypermethylation was observed at the CCND1 locus in the cyclin D1- U266 MM cell lines that had lost the active CCND1 locus with inserted IgH regulatory elements. Thus, transallelic effects at the CCND1 locus are observed with inserted as well as translocated IgH sequences.
###end p 24
###begin title 25
Monoallelic histone acetylation patterns at the cyclin D1 loci
###end title 25
###begin p 26
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 788 796 788 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 887 895 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
To determine if posttranslational histone modifications such as histone acetylation were coordinately involved with DNA methylation in transallelic effects at the cyclin D1 locus, histone acetylation patterns in the cyclin D1- genetic variants and parental cell lines were studied by chromatin immunoprecipitation (ChIP) assays. In contrast to the parental cell lines, the cyclin D1 coding and promoter regions and sequences extending 3 kb upstream were histone H3 and H4 deacetylated in the mutant cell lines, consistent with the DNA methylation patterns and the lack of transcription of the cyclin D1 gene. However, regions far upstream of the cyclin D1 gene, including the MTC, P519, and the IgH regulatory regions, remained histone H3 and H4 hyperacetylated in the mutant cell lines (Fig. 4 B) (4). Similar results were obtained with specific antibodies to acetyl H3 lysine 9 (AcK9; Fig. 4 C).
###end p 26
###begin p 27
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histone acetylation analyses in parental and cyclin D1<sup>&#8722;</sup> MCL lines.</bold>
###xml 110 118 110 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 412 417 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 507 512 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyeOV</italic>
###xml 529 534 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 797 802 793 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 971 973 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1113 1118 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Histone acetylation analyses in parental and cyclin D1- MCL lines. (A) Map of the 11q13 and 14q32 loci, as in Fig. 1 A. Primers used and their positions relative to the CCND1 and Calpha genes are shown. (B) ChIP assays with antibodies to acetylated histones H3 and H4 demonstrated hyperacetylation in the parental cell lines Granta (G) and NCEB (N), and hypoacetylation in the mutant cell lines G4 and N1 at the CCND1 promoter and upstream 3-kb (UP3K) regions. The other regions, including upstream regions MyeOV, MTC, P519, the CCND1 gene intron 4, and the IgH regulatory elements showed high levels of histone acetylation. (C) ChIP assays of H3 AcK9 showing a similar pattern as that obtained in B. White lines indicate that intervening lanes have been spliced out. (D) Schematic diagram of the CCND1 gene showing the location of the primers (left and right arrows) used for PCR and the polymorphic BsrI/NciI site, located in the last codon of exon 4 (A870G; reference 30). BsrI digestion of the PCR products distinguishes two alleles: allele A (145 and 22 bp) and allele G (167 bp). (E) ChIP RFLP assay of the CCND1 promoter region in U266 cells. Acetylated histones are only detected on the translocated allele, suggesting no transvection effects as observed with DNA methylation. N, normal allele; T, translocated allele.
###end p 27
###begin p 28
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 569 577 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 805 810 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Because the changes in histone acetylation observed in the mutant cells were also consistent with the loss of the histone H3 and H4 acetylated, translocated allele, allele-specific histone acetylation assays were performed. Specifically, we wished to determine whether both the translocated and nontranslocated CCND1 alleles in the parental cells contained acetylated histones. Allele-specific patterns of histone acetylation were studied in the U266 MM cell line, whose cyclin D1 alleles can be distinguished by a polymorphism at the cyclin D1 intron/exon 4 junction (Fig. 4 D). Allelic ChIP assays performed on U266 cells indicated that acetylated histones were only present on the translocated allele (Fig. 4 E), suggesting that histone acetylation was not participating in transallelic effects at the CCND1 locus.
###end p 28
###begin title 29
Reintroduction of the translocated t(11;14) alters DNA methylation in trans
###end title 29
###begin p 30
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 645 660 645 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A and B</xref>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 841 852 841 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, C&#8211;F</xref>
###xml 930 935 930 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1098 1103 1098 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1111 1119 1111 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 175 180 <span type="species:ncbi:9606">human</span>
Somatic cell fusion experiments have been used to study the contribution of individual alleles to both the transcription and DNA methylation status of several genetic loci in human malignancy (28, 29). Thus, cell fusion was used to determine if reintroduction of the translocated chromosome into the mutant cell lines where the CCND1 locus was methylated was capable of effecting transhypomethylation of the methylated allele. The Granta cell line (CCND1 hypomethylated) was fused with the N1 cell line (CCND1 methylated) to enable use of a DNA polymorphism within the CCND1 gene (30) to distinguish the translocated from the normal CCND1 loci (Fig. 5, A and B). All of the hybrid (G/N1) clones isolated contained both the untranslocated CCND1 locus from N1 cells and the translocated CCND1 locus from Granta cells, and expressed cyclin Dl (Fig. 5, C-F). No hybrid clones could be isolated that contained only the nontranslocated CCND1 loci (see Discussion). RFLP analysis demonstrated that cyclin D1 gene expression in these G/N1 hybrid clones originated from the Granta cell-derived translocated CCND1 locus (Fig. 5 E).
###end p 30
###begin p 31
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characterization and analysis of G/N1 hybrid cells.</bold>
###xml 228 236 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 773 778 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 867 872 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1080 1085 1080 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1189 1194 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Characterization and analysis of G/N1 hybrid cells. (A) Schematic diagram of the somatic cell fusion strategy used to generate G/N1 hybrid cells. (B) Schematic diagrams showing the location of the primers (arrows) used for PCR (Fig. 4 D) or RT-PCR and the polymorphic BsrI/NciI site (A870G; reference 30). BsrI or NciI digestion of the PCR or RT-PCR products distinguishes two alleles (A and/or G). (C) Allelic CCND1 gene PCR-RFLP analysis. Granta cells had the GG genotype, the mutant cell line N1 had the A genotype, and G/N1 hybrid cells had the AG genotype. (D) RT-PCR analysis demonstrated cyclin D1 expression in the G/N1 hybrid cells. Granta was used as positive control. N1 was used as a negative control and actin was used as an amplification control. (E) Allelic CCND1 RT-PCR analysis. The hybrid cells contain the translocated and transcriptionally active CCND1 locus, as in Granta cells. N1 and N cells were used as controls. (F) Southern blot analysis of the genomic DNA cleaved with BamH1 from Granta (G) and G/N1 hybrid cells shows both the normal and translocated CCND1 loci. (G) Southern blot analysis of DNA methylation in the G/N1 hybrid, Granta, and N1 cell lines. The CCND1 promoter region and upstream regions P519 and MTC are hypomethylated in G/N1 hybrid cells.
###end p 31
###begin p 32
###xml 79 87 79 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 G</xref>
###xml 122 128 122 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 456 462 456 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 719 724 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1061 1069 1061 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 1137 1142 1137 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
DNA methylation in the hybrid G/N1 cells was analyzed using Southern blotting (Fig. 5 G) and sodium bisulfite sequencing (Fig. 6) to determine whether introduction of the translocated CCND1 locus was capable of effecting transhypomethylation of the methylated allele. A 1:1 mix of the two parental DNAs and DNAs from nonhomologous clones were used as controls (Fig. S2, available at ). Analysis of DNA methylation patterns by bisulfite sequencing and MSP (Fig. 6) demonstrated that the translocated CCND1 locus was able to effect DNA hypomethylation at the promoter and 3 kb upstream of the promoter from the unrearranged, methylated CCND1 allele in G/N1 hybrid cells containing both the translocated and nonrearranged CCND1 loci. Extensive hypomethylation of the upstream 3-kb region was observed, but the transhypomethylation at the CCND1 promoter was incomplete in G/N1 hybrids. DNA methylation was reevaluated in these hybrid cells after multiple rounds of DNA replication to determine if the transhypomethylating effect at the promoter could be magnified (Fig. 6 B). In fact, DNA replication was associated with a small increase in CCND1 promoter methylation.
###end p 32
###begin p 33
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transallelic effects are specific to t(11;14).</bold>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 324 332 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 537 545 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 818 823 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 958 963 898 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1165 1172 <span type="species:ncbi:9606">patient</span>
Transallelic effects are specific to t(11;14). (A) Granta cells demonstrated minimal DNA methylation in the CCND1 gene promoter region. G/N1 hybrid cells showed approximately20% methylation, whereas the 1:1 mixture of Granta and N1 showed approximately50% methylation (approximately100% methylation in N1 cells, as shown in Fig. 3 C; and Fig. S2, available at ). Low-level DNA methylation was found in the upstream 3-kb region in both Granta and hybrid (G/N1) cells, whereas N1 cells displayed approximately100% methylation, as shown in Fig. 3 C. (B) Methylation levels in hybrid cells increased to approximately40% with culture (G/N1 late). (C) Hybrid cells treated with 5-azacytidine alone (G/N1 aza) or the combination of 5-azacytidine and trichostatin A (G/N1 TSA + aza) showed decreased methylation levels at the CCND1 gene promoter region compared with untreated cells (B) or cells treated with trichostatin A alone (G/N1 TSA). (D) MSP analysis at the CCND1 3-kb upstream region was performed as in Fig. S1. Methylation was observed in N1, U7, and LCL/N1 hybrid cells but not in parental NCEB, U266, or hybrid G/N1 cells, or in the malignant lymphocytes of a patient with a 11q- deletion and no t(11;14).
###end p 33
###begin p 34
###xml 152 160 152 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Treatment of these hybrid cells with a DNA hypomethylating agent (5-azacytidine) and/or a histone deacetylase inhibitor (trichostatin A) was performed (Fig. 6 C). Treatment with 5-azacytidine alone or in combination with trichostatin A led to almost total DNA hypomethylation at the CCND1 promoter in the hybrid cells, whereas treatment with trichostatin A alone did not change DNA methylation patterns.
###end p 34
###begin p 35
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 511 519 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
Because hybrid clones containing only the nontranslocated CCND1 locus could not be isolated (see Discussion), control fusions were performed using N1 and lymphocyte cell line (LCL) cells to investigate the effects of introduction of a nontranslocated, hypomethylated CCND1 locus (4) on the densely methylated CCND1 locus in N1 cells. MSP analysis of the CCND1 3-kb upstream region demonstrated that in contrast to G/N1 cells, LCL/N1 hybrid cells did not demonstrate hypomethylation in trans at the CCND1 locus (Fig. 6 D).
###end p 35
###begin p 36
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 610 618 610 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 203 210 <span type="species:ncbi:9606">patient</span>
###xml 371 378 <span type="species:ncbi:9606">patient</span>
###xml 552 559 <span type="species:ncbi:9606">patient</span>
To further demonstrate that transallelic effects in MCL were specific to t(11;14), malignant lymphoid cells that had deleted one CCND1 allele without the presence of t(11;14) were studied. A variant MCL patient (31) with marked peripheral blood lymphocytosis was identified (expressing cyclin D3 and no cyclin D1 mRNA; not depicted). FISH analysis demonstrated that this patient's malignant B cells contained a deletion of one allele of chromosome 11q, including the cyclin D1 locus (Fig. S3, available at ), and no t(11;14). MSP analysis of this 11q- patient's DNA demonstrated a hypomethylated CCND1 allele (Fig. 6 D). Thus, transallelic effects were specific to the presence of the translocated CCND1 locus.
###end p 36
###begin title 37
CTCF, NPM, and the nucleolus are associated with cyclin D1 activation and transvection
###end title 37
###begin p 38
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 196 202 196 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 735 740 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 861 866 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 939 947 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 1188 1196 1170 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 971 974 <span type="species:ncbi:8790">Emu</span>
###xml 1048 1051 <span type="species:ncbi:8790">Emu</span>
ChIP assays were used to screen parental versus variant cyclin D1- G4 cells for DNA binding proteins that would demonstrate selective binding to the translocated, transcriptionally active allele (Fig. 7). Proteins were assayed that have been reported to bind to the CCND1 promoter in vitro or whose potential consensus binding sites are located in the CCND1 promoter and IgH regulatory regions (32-35). Our results demonstrated that CTCF, Oct2, and Sp1 exhibited selective in vivo binding at the CCND1 promoter region in G versus G4 cells, whereas OCA-B (Bob-1), NF-kappaB, or a subunit of NF-kappaB (Rel-B) did not. Additional ChIP assays were performed to further study in vivo DNA-protein interactions of CTCF, Oct2, and Sp1 at the CCND1 promoter, and IgH regulatory regions in cyclin D1-expressing and control cell lines. Oct2, Sp1, and CTCF binding to the CCND1 promoter region correlated with cyclin D1 gene expression in MCL cells (Fig. 7 B). Primers from the IgH Emu enhancer 3' Calpha LCR regions showed CTCF, Oct2, and Sp1 binding to the Emu enhancer in both MCL and LCL cells. CTCF but not Oct2 or Sp1 binding to 3' Calpha LCR HS3 and HS4 correlated with cyclin D1 expression (Fig. 7 B).
###end p 38
###begin p 39
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CTCF and NPM bind to the <italic>CCND1</italic> loci and selectively to 3&#8242; IgH regulatory elements in MCL cells.</bold>
###xml 413 418 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 563 568 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 833 838 823 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 951 956 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1066 1071 1056 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1178 1183 1164 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1422 1427 1408 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1498 1500 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 693 696 <span type="species:ncbi:8790">Emu</span>
###xml 765 768 <span type="species:ncbi:8790">Emu</span>
CTCF and NPM bind to the CCND1 loci and selectively to 3' IgH regulatory elements in MCL cells. (A) CTCF, Oct2, and Sp1 showed differential binding in the parental cell line Granta (G) and the mutant cell line G4. OCA-B/Bob-1, NF-kappaB, and Rel-B showed similar low levels of binding in both cell lines. White lines indicate that intervening lanes have been spliced out. (B) CTCF, Oct2, and Sp1 are bound to the CCND1 promoter and IgH regulatory regions in MCL cell lines. EBV-transformed B lymphocytes LCL1 and LCL2 showed binding of CTCF, Oct2, and Sp1 at the CCND1 promoter region, whereas cyclin D1 mRNA was not expressed in these cells. Oct2 and Sp1 bound to the IgH regulatory elements Emu and 3' Calpha HS4 and HS3, whereas CTCF was only found bound to the Emu intronic enhancer in LCL1. CTCF, Oct2, and Sp1 all bound to the CCND1 promoter region. H, HL60 myeloid cells; M, Manca Burkitt's lymphoma cells. (C) CTCF binding was enriched at the CCND1 promoter and IgH regulatory sequences. (D) NPM binding is similar to that of CTCF in Granta MCL cells at the CCND1 locus and IgH regulatory sequences. (E) Model of CTCF tethering of the 3' Calpha IgH enhancers (E) to the CCND1 promoter (P) through interaction at the nucleolar periphery. CTCF functions to juxtapose enhancer and promoter by tethering them to the nucleolus through interaction with NPM. CTCF is also postulated to tether the normal and translocated CCND1 loci, thus facilitating transallelic effects (modified from reference 20).
###end p 39
###begin p 40
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 106 114 106 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 210 215 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 301 309 293 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
The binding of CTCF at the CCND1 locus and IgH regulatory regions was further examined using ChIP assays (Fig. 7 C). Although binding at IgH 3' Calpha LCR HS3 and HS4 only occurred in cell lines that expressed CCND1, primers for 3' Calpha HS12 demonstrated binding of CTCF in all cell lines examined (Fig. 7 C). Collectively, these results suggested that 3' Calpha HS3 and HS4 binding by CTCF could be important in deregulated cyclin D1 expression in MCL.
###end p 40
###begin p 41
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
Western blot analyses were performed to assay the level of these proteins in the cell lines used (Fig. S4, available at ). cyclin D1 protein was detected in the MCL cell lines Granta and NCEB, and the breast cancer cell line MCF7, consistent with RT-PCR assays (4). The transcription factors CTCF, Oct2, and Sp1 were detected in all cell lines examined. Thus, the specific binding of CTCF observed was not secondary to variations in the levels of this protein in MCL cells.
###end p 41
###begin p 42
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 D</xref>
###xml 422 427 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 580 585 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 627 635 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 E</xref>
CTCF has been shown to interact with the nucleolar protein NPM to tether an insulator sequence to subnuclear sites at the nucleolar periphery (21). ChIP assays demonstrated binding of NPM at the CCND1 promoter and IgH regulatory regions in MCL cells, similar to results obtained with CTCF (Fig. 7 D). These results suggested a potential role for CTCF in juxtaposing 3' Calpha IgH regulatory elements (HS3 and HS4) and the CCND1 promoter by tethering them to the nucleolar periphery with NPM. CTCF and NPM could also play a role in mediating pairing of the translocated and normal CCND1 loci, facilitating transallelic effects (Fig. 7 E).
###end p 42
###begin p 43
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 444 452 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 825 840 825 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, A and B</xref>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 982 990 982 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 1039 1044 1039 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
If CTCF and NPM were involved in tethering the CCND1 loci together, evidence of binding of these proteins to both CCND1 alleles would be expected. Allelic ChIP assays were performed with antibodies to CTCF, NPM, and RNA polymerase II (Pol II). MCF7 cells, a cyclin D1-expressing breast cancer line without the t(11;14) translocation, demonstrated biallelic transcription of cyclin D1 (30) as well as biallelic binding of Pol II, NPM, and CTCF (Fig. 8 B). An EBV LCL (LCL1) that does not express cyclin D1 demonstrated no binding of Pol II or CTCF at either allele, whereas the CCND1 loci in this cell line are CpG hypomethylated and histone H3 and H4 are hyperacetylated (4). U266 MM cells only transcribed the CCND1 allele containing the IgH insertion, as shown by RT-PCR analysis and ChIP analysis using Pol II antibodies (Fig. 8, A and B). However, CTCF and NPM ChIP DNA from U266 but not LCL cells contained sequences from both the transcribed and nontranscribed CCND1 alleles (Fig. 8 B). Thus, both the transcribed and nontranscribed CCND1 loci bind CTCF and NPM, consistent with our hypothesis that CTCF and NPM are involved in tethering these loci together.
###end p 43
###begin p 44
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CTCF and NPM bind at both the translocated and normal <italic>CCND1</italic> alleles.</bold>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 533 541 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 913 919 913 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1015 1020 <span type="species:ncbi:10090">Mouse</span>
CTCF and NPM bind at both the translocated and normal CCND1 alleles. (A) Allelic CCND1 RT-PCR assay. The 145-bp fragment corresponds to the translocated and transcribed CCND1 locus in U266 cells, whereas the 164-bp fragment corresponds to the translocated locus in Granta cells. Both CCND1 loci of MCF7 cells are transcribed. N, normal; T, translocated CCND1 alleles. (B) Allelic ChIP assays. CTCF and NPM binding is seen on both CCND1 loci and Pol II binding only on the translocated and transcribed locus (145-bp band shown, as in Fig. 5 B) in U266. MCF7 cells bind CTCF and Pol II at both CCND1 loci, and an LCL B cell line showed no binding of CTCF and Pol II. (C) ReChIP assay of CTCF and NPM binding to the CCND1 locus in MCL cells. ChIP assays with CTCF and NPM antibodies sequentially in both combinations were performed in HBL-2 MCL cells. PCR analysis with primers from the CCND1 locus (10 kb upstream; Fig. 4) demonstrated that CTCF and NPM were bound together at the cyclin D1 locus in HBL-2 MCL cells. Mouse IgG and no antibody controls showed no binding. White lines indicate that intervening lanes have been spliced out.
###end p 44
###begin p 45
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 340 348 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
To provide further evidence that CTCF and NPM were directly cobinding at the CCND1 locus, sequential ChIP (36) assays were performed on the EBV-negative MCL cell line HBL-2 (37) using sequential IP assays with anti-CTCF and NPM antibodies. These results demonstrated that CTCF and NPM were binding together at the CCND1 locus in MCL cells (Fig. 8 C).
###end p 45
###begin p 46
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 370 385 370 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, A and G</xref>
###xml 457 465 457 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 B</xref>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 603 631 603 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, B and C; and G and H</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 849 857 849 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 H</xref>
###xml 867 872 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 955 960 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1025 1026 1025 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 447 455 <span type="species:ncbi:9606">patients</span>
FISH analysis combined with NPM immunofluorescent FISH (immunoFISH) staining was used to visualize the position of the CCND1 loci in relationship to the nucleolus. Fixation protocols using methanol/acetic acid or paraformaldehyde alone, or in combination, yielded similar results. The CCND1 locus colocalized at the nucleolar periphery in CCND1-translocated cell lines (Fig. 9, A and G) and in neoplastic cyclin D1-expressing lymphocytes from MCL patients (Fig. 9 B; and Fig. S5, available at ). Pairing of the CCND1 loci at the nucleolus was also observed, as indicated by two juxtaposed FISH signals (Fig. 9, B and C; and G and H). The paired CCND1 loci observed were unlikely to be caused by replicated but unseparated sister chromatids, because the same frequency of pairing was observed in flow-sorted Granta nuclei in the G1 cell cycle phase (Fig. 9 H). Paired CCND1 loci were not observed in cyclin D1-expressing MCF7 cells and LCL cells where the CCND1 locus was hypomethylated and histone H3 and H4 were acetylated (4).
###end p 46
###begin p 47
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CTCF and NPM participate in tethering of the translocated and nontranslocated <italic>CCND1</italic> loci at the nucleolus.</bold>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1094 1099 1094 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1522 1527 1522 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1617 1622 1617 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1638 1643 1638 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 478 485 <span type="species:ncbi:9606">patient</span>
###xml 1580 1588 <span type="species:ncbi:9606">patients</span>
CTCF and NPM participate in tethering of the translocated and nontranslocated CCND1 loci at the nucleolus. (A) immunoFISH assays demonstrate colocalization of CCND1 probe (green) and NPM protein (red) at the nucleolar periphery in Granta MCL cells (merge; yellow). DAPI-stained nuclei are shown in blue. (B) immunoFISH assays (as in A). Paired CCND1 loci as demonstrated by two juxtaposed FISH spots (arrows) colocalize with nucleoli in cells from Granta cells (top) and an MCL patient (bottom). Insets show different fields of view. (C) immunoFISH assays of Granta cells with CCND1 (red) /IgH (green) probes and NPM antibodies (Cy5; gray), demonstrating colocalization of both translocated chromosome partners (yellow) at the nucleolar periphery. (D) G4 cells lacking the translocated CCND1 locus exhibit colocalization of the CCND1 FISH signal with the nucleoli. (E) immunoFISH assay of MCF7 cells (FISH probes as in D) demonstrates no colocalization of the CCND1 locus with the nucleoli. (F) immunoFISH assay of LCL1 B lymphocytes (FISH probes as in D) demonstrates no colocalization of the CCND1 locus with the NPM-stained nucleoli. (G) Z stack images (deconvolution microscopy; FISH probes as in D) show nucleolar colocalization of translocated chromosomes in Granta cells. Nucleoli are blue and DAPI-stained nuclei are gray. The nucleoli are seen as DAPI-poor staining regions (FISH-DNA) that stain with anti-NPM antibodies (FISH-DNA NPM). (H) Quantitative analysis of the percentage of nucleolar colocalization and CCND1 locus pairing in Granta cells, cells from three MCL patients (Pts), and MCF7 cells using CCND1 (D1; see A-C), CCND1/IgH fusion (Trans; probe used in D-G), FISH probes, and NPM antibodies. At least 100 nuclei were scored per sample. G1 cell cycle phase nuclei isolated by flow cytometry were used. Error bars show SEM. Bars, 5 mum.
###end p 47
###begin p 48
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 257 272 257 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, D and H</xref>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 650 665 650 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, E and F</xref>
###xml 515 522 <span type="species:ncbi:9606">patient</span>
In MCL cells that lost the translocated CCND1 locus (G4), the nontranslocated chromosome 11 remained associated with the nucleolus, providing further evidence that pairing of the cyclin D1 loci at the nucleolus was occurring in the parental MCL cell lines (Fig. 9, D and H). These observations demonstrated the nucleolar environment is capable of both activation and repression functions at the CCND1 loci in MCL cells (see Discussion). In cyclin D1-expressing MCF7 cells, B lymphocytes (LCLs), and the variant MCL patient (Fig. S4) that do not contain the t(11;14) translocation, colocalization of the CCND1 loci and the nucleolus was not observed (Fig. 9, E and F; and not depicted).
###end p 48
###begin p 49
###xml 349 358 349 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 A</xref>
###xml 509 518 509 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 B</xref>
###xml 612 621 612 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 C</xref>
###xml 863 872 863 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 D</xref>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 C</xref>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 1391 1396 1391 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1426 1435 1426 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 E</xref>
###xml 1523 1528 1523 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1633 1642 1633 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 B</xref>
###xml 1680 1685 1680 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 1821 1826 1821 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
To further investigate the role of the nucleolus and NPM in deregulated cyclin D1 expression in t(11;14) B cell malignancies, we used NPM short hairpin RNA (shRNA) to knock down levels of NPM. Cell growth was specifically inhibited by NPM shRNA in cell lines containing a t(11;14) but not in B lymphocytes without this translocation and MCF7 cells (Fig. 10 A). Western blotting demonstrated significant knockdown of NPM protein levels but no change in cyclin D1 protein levels in either MCF7 or Granta cells (Fig. 10 B). Western analysis showed a marked decrease in NPM levels in cells containing the NPM shRNA (Fig. 10 C). The NCEB MCL cell line demonstrated marked morphological changes that were consistent with apoptosis and were confirmed by Tdt-mediated dUTP-biotin nick-end labeling (TUNEL) assays. Lower levels of apoptosis were observed in Granta cells (Fig. 10 D), and minimal apoptosis was seen in G4 and N1 cells (Fig. S6, available at ). MCF7 and K562 erythroleukemia cells treated with the NPM but not control shRNA vectors showed loss of nucleolar NPM staining, and CTCF, cyclin D1, and residual NPM staining in the cytoplasm (Fig. 10 C). These results are consistent with the role of NPM as a shuttle protein (38) and suggest that CTCF and cyclin D1 are among the proteins regulated by NPM. immunoFISH assays revealed no significant change in nucleolar colocalization of the CCND1 loci in NPM knockdown cells (Fig. 10 E), suggesting that additional layers of complexity are involved in the tethering of the CCND1 loci in MCL cells. NPM knockdown cells also did not demonstrate any change in cyclin D1 protein levels (Fig. 10 B), suggesting that NPM binding at the CCND1 locus was not directly involved in regulating expression of the cyclin D1 gene but could be serving a structural role in tethering the CCND1 loci to the nucleolus.
###end p 49
###begin p 50
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NPM knockdown in MCL and control cells.</bold>
NPM knockdown in MCL and control cells. (A) Growth of cells containing t(11;14) translocations is inhibited with NPM shRNA. Cells were infected with retroviruses containing either an NPM (red) or a control (blue) shRNA. Cell growth was specifically inhibited in cells with t(11;14) translocations. (B) Western blot analysis of protein levels of cyclins D1, D3, NPM, and alpha-tubulin genes after infection with NPM shRNA virus. NPM levels are reduced, whereas levels of cyclins D1 (Granta and MCF7) and D3 (K562) are unchanged. (C) Immunofluorescent staining of NCEB, MCF7, and K562 cells after transfection with NPM shRNA vector. NPM shRNA-infected NCEB cells show dramatic morphological changes. MCF7 cells demonstrated cyclin D1 and CTCF cytoplasmic protein staining. K562 erythroleukemia cells also demonstrate cytoplasmic NPM and CTCF staining. Granta NPM shRNA-treated cells do not show cytoplasmic localization of NPM or cyclin D1. (D) TUNEL assays of NPM and control shRNA MCL cells. Fig. S6 (available at ) shows control shRNA vector-infected cells. (E) immunoFISH assay of NPM knockdown Granta cells demonstrates no significant change in the percentage of cells showing nucleolar localization. Error bars in A, D, and E show SEM. Bars, 5 mum.
###end p 50
###begin title 51
DISCUSSION
###end title 51
###begin p 52
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Previously, the DNA methylation patterns of the 11q13 region surrounding the CCND1 gene in MCL and MM cells were examined (4). The activation of the cyclin D1 gene by IgH regulatory elements was found to correlate with the absence of DNA methylation at the CCND1 promoter. Interestingly, this domain of hypomethylated DNA appears to be present not only on the translocated but also on the untranslocated allele. Normal B cells and EBV lymphocytes also displayed extensive DNA hypomethylation and hyperacetylation of histones at the CCND1 loci, although the CCND1 gene is not expressed (4). Hypomethylation up to 90 kb upstream of the CCND1 promoter was eliminated with loss of the translocated chromosome initiated through a gene targeting event.
###end p 52
###begin p 53
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 532 538 532 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 989 995 989 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 1114 1116 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 1234 1239 1234 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
Somatic cell hybrid fusions indicated that reintroduction of the translocated chromosome but not a nontranslocated chromosome was capable of transhypomethylating a densely methylated CCND1 locus. The Granta cells used in the fusion experiments that reintroduced the t(11;14) chromosome into N1 cells also contained a nontranslocated CCND1 locus that possessed the identical cyclin D1 polymorphism as the translocated CCND1 locus. The recipient N1 cell line possessed a different, distinguishable polymorphism in the cyclin D1 gene (Fig. 5). All of the hybrid clones isolated contained the translocated chromosome. We were unable to isolate clones that contained only the nontranslocated CCND1 locus from Granta cells. Thus, the translocated and nontranslocated CCND1 loci could not be segregated. This result provides further, albeit indirect, evidence that the translocated and nontranslocated cyclin D1 loci are tethered together (at the nucleolus), as suggested by our immunoFISH data (Fig. 9). Alternatively, defects in DNA methylation have been associated with chromosomal instability, both in embryogenesis (39) and in colorectal cancer cell lines (40). Therefore, another possibility is that the hypomethylated nontranslocated CCND1 locus was unstable and was lost during the cell fusion process.
###end p 53
###begin p 54
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
Control fusion experiments indicated that fusion of N1 cells with a B lymphocyte line without a translocated chromosome was unable to hypomethylate the densely methylated cyclin D1 locus of N1 cells in trans. Similar results using other systems demonstrated no trans epigenetic effects with nontranslocated chromosomes (28, 29).
###end p 54
###begin p 55
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
Because the CCND1 locus is extensively hypomethylated in normal B cells, at least three DNA methylation states of the CCND1 loci are implied: (a) normal B cells in where both CCND1 loci are unmethylated and independent; (b) B cells containing CCND1 translocations/insertions, where the translocated locus exerts a transhypomethylating effect on the untranslocated locus; and (c) B cells that have lost the translocated chromosome and where the CCND1 locus is CpG methylated. The second and third DNA methylation states are dependent on localization at the nucleolus, whereas the second DNA methylation state appears to be associated with pairing of the CCND1 loci. Thus, the association of genetic loci with the nucleolus can result in either active (state 2) or inactive (state 3) chromatin, consistent with the results obtained in other systems (21, 41). The mechanisms involved in gene expression or repression by association with the nucleolus remain obscure, but could be related to the ability of the translocated allele to recruit activator molecules that protect the tethered cyclin D1 loci from the general repressive effects of the nucleolus. There may also be subtle differences in nucleolar localization that may be important in epigenetic activation versus repression.
###end p 55
###begin p 56
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 196 206 196 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 196 206 <span type="species:ncbi:7227">Drosophila</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
The change in DNA methylation patterns observed in the normal CCND1 locus after loss of the translocated chromosome are consistent with transallele sensing effects (42), which are well studied in Drosophila (transvection; references 42-44) and plants (paramutation) (13-15). Trans effects in both endogenous and transgenic mouse loci have been reported (45-49). Such effects often involve DNA methylation and occur over long distances (45, 46, 48). Transactivation of the endogenous Igf2 gene by trangenes has been reported (49), but given the results reported in this paper, transallelic effects should be considered.
###end p 56
###begin p 57
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 98 107 98 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U2af1rs-1</italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-kit</italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 23 38 <span type="species:ncbi:10090">transgenic mice</span>
###xml 177 182 <span type="species:ncbi:9606">human</span>
Recent observations in transgenic mice have described paramutation-like effects at the Igf2 (45), U2af1rs-1 (46), c-kit (47), and Rosa26 (48) loci. Paramutation/transvection in human genetic disease associated with the susceptibility to type I diabetes has been suggested at the insulin minisatellite variable number tandem repeat element (50). However, our observed transallelic effects are similar to transvection but differ from paramutation because the DNA transhypomethylation effects are not heritable in the absence of the inducer (translocated) allele (14).
###end p 57
###begin p 58
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2/H19</italic>
###xml 175 183 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wsb1/Nf1</italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 283 291 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2/H19</italic>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
Physical evidence of transcommunication has recently been observed between loci on nonhomologous chromosomes regulated by the T cell enhancers/LCRs (51), and the Igf2/H19 and Wsb1/Nf1 loci (52). CTCF has been demonstrated to be involved in long-distance cis and trans effects at the Igf2/H19 locus (52, 53). Thus, transcommunication may be an important means of regulation in mammalian cells.
###end p 58
###begin p 59
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 247 252 <span type="species:ncbi:10090">mouse</span>
At least two nonexclusive mechanisms are implicated in the homology-based transfer of DNA methylation patterns (14). One mechanism involves direct communication between homologous chromosomes, as has been demonstrated in imprinted loci (54) or in mouse embryonic stem cells at the onset of X inactivation (55). Recent work has shown that CTCF is required for this transient X chromosome pairing (56). The nucleolus has also been implicated in silencing of the inactive X chromosome using immunoFISH assays similar to those performed in this study (57). Our FISH and allelic ChIP data provide evidence for direct communication of the CCND1 alleles in MCL cells that we suggest is mediated via CTCF, NPM, and the nucleolus.
###end p 59
###begin p 60
###xml 107 117 107 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-kit</italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 107 117 <span type="species:ncbi:7227">Drosophila</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
Alternatively, small RNA molecules have been shown to direct chromatin modification in trans in plants and Drosophila (13, 14, 58-61). This epigenetic silencing mechanism involves CpG and non-CpG DNA methylation in plants. Tandem and inverted repeats have been shown to be involved in this type of RNA-mediated repression (58-61). More recently, a paramutation-like effect mediated by small RNAs has been described at the mouse c-kit locus (47).
###end p 60
###begin p 61
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 E</xref>
Our allelic ChIP and immunoFISH data suggest that CTCF and NPM participate in transallelic interactions by tethering the cyclin D1 loci from both translocated and nontranslocated cyclin D1 loci together at the nucleolar periphery, as depicted in Fig. 7 E. Our data demonstrate that the 3' Calpha IgH LCR region is sufficient to mediate this effect and that CTCF binding to 3' Calpha LCR HS3 and HS4 correlates with cyclin D1 activation in MCL cells.
###end p 61
###begin p 62
###xml 125 130 <span type="species:ncbi:9606">human</span>
Our finding in cyclin D1-deregulated B cell malignancies represents the first report of the association of transvection with human cancer. The critical role of NPM in t(11;14) B cell malignancies is demonstrated by growth arrest and apoptosis selectively in t(11;14) cell lines with NPM shRNA. Our data also suggest a novel approach to therapy of t(11;14) malignancies using agents targeting NPM.
###end p 62
###begin title 63
MATERIALS AND METHODS
###end title 63
###begin title 64
Cell culture, electroporation, and retroviral infection.
###end title 64
###begin p 65
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 165 171 165 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 389 391 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
Cell lines were obtained and maintained as previously described (4). The HBL-2 MCL cell line (37) was provided by S. Dave (National Cancer Institute, Bethesda, MD). Fig. 1 shows details of gene targeting constructs. Electroporations were performed, as previously described (22), using 10-20 mug of linearized targeting vector. Retroviral infections were performed as previously described (62).
###end p 65
###begin title 66
FISH/immunoFISH.
###end title 66
###begin p 67
###xml 6 8 6 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">64</xref>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 412 418 412 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
FISH (63) and immunoFISH (64) were performed as previously described. For immunoFISH, cells were fixed using 4% paraformaldehyde, methanol/acetic acid (3:1), and methanol/acidic acid, followed by paraformaldehyde with similar results. For two-color immunoFISH, a combination of CCND1 probes from chromosome 11 (9) was labeled by nick translation (63). Three-color immunoFISH used a t(11;14) fusion probe (Vysis; Fig. 1). Cy5-conjugated anti-mouse secondary antibody (Invitrogen) was used with anti-NPM antibody after FISH, according to the supplied protocol. Deconvolution microscopy (Deltavision) was performed using the OHSU core facility. Granta cells were stained with Hoechst dye, and G1 cells were isolated by flow cytometry for immunoFISH analysis. At least 100 cells were assayed per cell line.
###end p 67
###begin p 68
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Peripheral blood or bone marrow was obtained from MCL patients giving informed consent under an OHSU institutional review board-approved Southwest Oncology Group study. Buffy coat was purified using Ficoll, as previously described (4).
###end p 68
###begin title 69
Somatic cell fusions.
###end title 69
###begin p 70
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
Somatic cell fusions were performed using polyethylene glycol, as previously described (65). Hybrids were selected using combined resistance to neomycin and hygromycin or hygromycin and puromycin.
###end p 70
###begin title 71
Southern blotting and bisulfite sequencing.
###end title 71
###begin p 72
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
Southern blotting and bisulfite sequencing were performed as previously described. At least 10 clones were sequenced for each bisulfite reaction (4). Hybridization probes and PCR primer sequences have been previously described (4).
###end p 72
###begin title 73
ChIP.
###end title 73
###begin p 74
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
ChIP assays were performed and PCR primers were used as previously described (4). Supplemental materials and methods (available at ) describes primers and antibodies.
###end p 74
###begin title 75
PCR-RFLP.
###end title 75
###begin p 76
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCND1</italic>
###xml 488 494 475 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
The CCND1 G/A polymorphism was detected by the PCR- RFLP method. A 167-bp fragment of the CCND1 gene at the junction of exon 4/intron 4 was amplified by PCR using 0.1 mug of genomic DNA at an annealing temperature of 64degreesC. For RFLP analyses, each PCR product was purified by gel extraction and digested with BsrI (ACTGGN/) at 50degreesC before electrophoresis. The DNA fragments were separated using a 3% 2:1 Nusieve/SeaKem agarose gel. The allele types were determined as shown in Fig. 4. Primer sequences are provided in Supplemental materials and methods.
###end p 76
###begin title 77
TUNEL assays.
###end title 77
###begin p 78
TUNEL assays were done according to the manufacturer's protocol (Roche). 300-500 nuclei were assayed per sample.
###end p 78
###begin title 79
Online supplemental material.
###end title 79
###begin p 80
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 314 321 <span type="species:ncbi:9606">patient</span>
###xml 479 486 <span type="species:ncbi:9606">patient</span>
Table S1 summarizes the FISH results demonstrating the absence of t(11;14) in the targeted clones. Fig. S1 shows the results of MSP analysis of parental and cyclin D1- clones. Fig. S2 shows the results of bisulfite sequencing mixing control experiments. Fig. S3 demonstrates FISH analysis of a cyclin D1- 11q- MCL patient. Fig. S4 shows Western blot analysis of proteins assayed by ChIP analysis in the cell lines used. Fig. S5 shows the results of staining of blood from an MCL patient with antibodies to cyclin D1 and NPM. Fig. S6 shows the results of TUNEL assays on control and NPM shRNA-treated cells. Supplemental results describes Fig. 1 D in detail. Supplemental materials and methods provides details about antibodies and PCR primers. Online supplemental material is available at .
###end p 80
###begin title 81
Supplementary Material
###end title 81
###begin title 82
[Supplemental Material Index]
###end title 82
###begin p 83
###xml 223 230 <span type="species:ncbi:9606">patient</span>
We thank Mark Groudine, William Forrester, Matt Lorincz, Richard Maziarz, Janine Lasalle, and Vicki Chandler for discussions and comments. Rich Fisher, Tom Miller, and the Southwest Oncology Lymphoma Committee provided MCL patient samples.
###end p 83
###begin p 84
This work was supported by grants from the National Institutes of Health (HL069133 and HL077818 to W.H. Fleming, and DK56798 to E. Epner), the International Myeloma Foundation (to E. Epner), and the Lymphoma Research Foundation (to E. Epner).
###end p 84
###begin p 85
The authors declare no financial conflicts of interest.
###end p 85

